Schadewaldt P, Beck K, Wendel U
Diabetes-Forschungsinstitut, Universität Düsseldorf, FRG.
Clin Chim Acta. 1989 Sep 15;184(1):47-56. doi: 10.1016/0009-8981(89)90255-6.
Branched-chain 2-oxo acid dehydrogenase activity in human skin fibroblasts against L-leucine, L-valine, L-isoleucine and derived 2-oxo acids was compared in incubations with 1 mmol/l of 1-14C-labelled substrate. The results suggested that the amino acids are the more suitable substrates for an estimation of decarboxylation activity in intact cells. In control cell lines (n = 12), 14CO2 release from amino acids was highest for valine and least for leucine. In a representative number of fibroblast strains of patients with different forms of MSUD (n = 11; residual decarboxylation activity 2-60% of the controls), 14CO2 release from the different amino acids was reduced to a similar degree. Additional measurement of 2-oxo[1-14C]acid release suggested that substrate supply to the branched-chain 2-oxo acid dehydrogenase complex was not rate limiting in the cell lines under investigation.
在含有1 mmol/l 1-¹⁴C标记底物的孵育实验中,比较了人皮肤成纤维细胞中支链2-氧代酸脱氢酶对L-亮氨酸、L-缬氨酸、L-异亮氨酸及其衍生的2-氧代酸的活性。结果表明,氨基酸是更适合用于评估完整细胞中脱羧活性的底物。在对照细胞系(n = 12)中,缬氨酸从氨基酸释放¹⁴CO₂的量最高,亮氨酸最低。在患有不同形式枫糖尿症(MSUD)的患者的代表性数量的成纤维细胞株中(n = 11;残留脱羧活性为对照的2-60%),不同氨基酸释放¹⁴CO₂的量均有相似程度的降低。对2-氧代[1-¹⁴C]酸释放的额外测量表明,在所研究的细胞系中,支链2-氧代酸脱氢酶复合物的底物供应不是限速因素。